Please note…

You are now on the ey.com Luxembourg site. To return to the ey.com United States site or other country site, click on the Luxembourg (English) link on the upper right of this page, and select your preferred country site.

x
Skip to main navigation

Life sciences: Driving innovation in a time of change - Ernst & Young - Luxembourg

Life sciences: the pulse of innovation

Life sciences companies — from emerging to multinational — are facing challenging times as stakeholder expectations are changing, development pipelines are declining and access to healthcare takes on new importance. Success requires flexible strategies and innovative business models.

Ernst & Young’s Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential — a team with deep technical experience in providing assurance, tax, transaction and advisory services.

Whether it’s forming the right alliances, improving operations, exploring new markets or gaining industry insights, we can help you execute for success in today’s complex, competitive and risk-driven environment.

Biotechnology

Biotechnology

Biotech companies are delivering new levels of health, prosperity and sustainability across the world.

Pharmaceutical

Pharmaceutical

Key drivers are reshaping the pharmaceutical marketplace, including the growing power of healthcare payers, providers and evolving customer needs.

Medical Technology

Medical technology

Fundamental drivers in the global healthcare economy suggest demand for medical technology products should be robust for years to come.

Life Sciences

Contacts

icon envelope  Pierre Mangers 
Executive Director
icon telephone + 352 42 124 7111

Businessman looking at departures in airport terminal  
Medical technology report 2011
Facing a confluence of risks, can medtech find new ways to sustain innovation? We explore. 

Beyond borders: global biotechnology report 2011 How sustainable is today’s biotechnology industry?
After slowly recovering from the recession, bigger companies are proving more successful than smaller ones. Will this trend continue and what changes are ahead for biotech. Learn more in our 25th anniversary edition of Beyond Borders. 

Back to top